Breast cancer continues to be one of the most diagnosed cancers among women worldwide, and early screening remains one of the strongest tools for reducing mortality. In 2023, OECD countries increased investments in diagnostic imaging infrastructure, especially mammography systems, to improve nationwide breast cancer detection programs. The number of mammography machines available per 1,000,000 population has become an important benchmark for measuring healthcare accessibility and screening readiness.
The latest OECD-linked healthcare technology data shows that the United States remained the global leader in mammography machine density in 2023, reporting 75.52 mammography units per one million people. This means the country had more than three times the OECD average and over six times the machine availability of several lower-ranked OECD nations. The high concentration of imaging infrastructure reflects the strong role of private healthcare providers, large hospital networks, and widespread preventive screening programs across the country.
South Korea ranked second with 69.46 mammography machines per million population. Over the last decade, South Korea has aggressively modernized its healthcare technology sector, expanding diagnostic imaging centers and digital screening programs. The country now operates one of the most technologically advanced cancer screening ecosystems in Asia. The difference between South Korea and the third-ranked country, Italy, was particularly notable, with Italy reporting only 35.41 machines per million people; almost half the Korean level.
Top OECD Countries by Mammography Machines per 1,000,000 Population (2023)
| Rank | Country | Mammography Machines per 1,000,000 Population |
|---|---|---|
| 1 | United States | 75.52 |
| 2 | South Korea | 69.46 |
| 3 | Italy | 35.41 |
| 4 | Australia | 23.19 |
| 5 | New Zealand | 21.87 |
| 6 | Austria | 21.40 |
| 7 | Norway | 21.27 |
| 8 | Ireland | 17.83 |
| 9 | Slovenia | 14.42 |
| 10 | Mexico | 11.41 |
The statistical gap between the top two countries and the remaining OECD members reveals major differences in healthcare investment patterns. The United States had approximately 6.6 times more mammography machines per capita than Mexico and more than double the density of Australia. Such differences can directly influence waiting times, access to preventive screening, and early-stage cancer diagnosis rates.
Another important trend in 2023 was the shift toward digital mammography and AI-assisted breast imaging systems. Countries including Norway, Australia, and South Korea expanded the installation of digital breast tomosynthesis systems, commonly called 3D mammography machines. These advanced systems improve cancer detection accuracy, particularly in women with dense breast tissue, while also reducing false-positive screening results.
Healthcare spending also strongly correlates with mammography availability. The United States spent nearly 16% of GDP on healthcare in 2023, among the highest globally, while South Korea increased public healthcare investments significantly after the pandemic. In contrast, countries with lower machine density often face budget limitations, rural healthcare access challenges, or shortages of trained radiology professionals.
OECD health experts continue to emphasize that machine availability alone is not enough. Screening participation rates, affordability, technician availability, and public awareness campaigns also determine how effectively countries can reduce breast cancer mortality. Still, the 2023 data clearly shows that nations investing heavily in mammography infrastructure are building stronger foundations for earlier diagnosis and improved long-term cancer outcomes.
Access our exclusive, data-rich dashboard dedicated to the medical imaging market – built specifically for decision-makers, strategists, and industry leaders. The dashboard features comprehensive statistical data, segment-wise market breakdowns, regional performance shares, detailed company profiles, annual updates, and much more. From market sizing to competitive intelligence, this powerful tool is one-stop solution to your gateway.
Access the Dashboard: https://www.towardshealthcare.com/access-dashboard
About Us
Healthcare WebWire is a sister firm of Towards Healthcare Research and Consulting, provides strategic insights across the medical imaging market, including MRI, CT, ultrasound, X-ray, nuclear imaging, and molecular imaging technologies. We help healthcare companies and imaging providers understand technology trends, optimize innovation strategies, and drive growth through data-driven market intelligence.
You can place an order or ask any questions, please feel free to contact us at sales@towardshealthcare.com
Europe Region – +44 778 256 0738
North America Region – +1 8044 4193 44
APAC Region: +91 9356 9282 04
Visit Our Website: https://www.towardshealthcare.com
Find us on social platforms: LinkedIn | Twitter | Instagram | Medium
Read More: